• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Protagenic Therapeutics, Inc. - Common Stock (NQ:PTIX)

    0.7400 UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.7400
    Bid (Size) 0.4400 (20,000)
    Ask (Size) 0.4999 (6,200)
    Prev. Close 0.7400
    Today's Range 0.7400 - 0.7400
    52wk Range 0.7400 - 3.320
    Shares Outstanding 1,810,208
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder
    From Protagenic Therapeutics, Inc.
    Via ACCESS Newswire
    News headline image
    Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
    From Protagenic Therapeutics, Inc.
    Via ACCESS Newswire

    Performance

    52-Week Range 77.7% below 52-week high
    0.7400
    0.7452W Low 3.3252W High

    Protagenic Therapeutics, Inc. - Common Stock (PTIX) traded between $0.74 and $3.32 over the past 52 weeks and last traded at $0.74, 77.7% below its 52-week high.

    Past 12 Months
    N/A
    N/A
    N/A
    N/A
    N/A
    -76.9%
    1W  
    1M  
    3M  
    6M  
    YTD  
    1Y -$2.46

    PTIX was -76.9% over the past year.

    12 Months vs Market
    PTIX
    -76.9%
    DIA
    +12.2%
    SPY
    +14.7%
    QQQ
    +17.9%
    IWM
    +8.0%

    Over the past 12 months PTIX returned -76.9% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

    Volume & Liquidity
    1Y
    80.4K

    More News

    Read More
    News headline image
    Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner
    Via ACCESS Newswire
    News headline image
    Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
    Via ACCESS Newswire
    News headline image
    Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
    Via ACCESS Newswire
    News headline image
    Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
    Via ACCESS Newswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Results from Phase 1 Multiple-Dose Study of PT00114
    Via ACCESS Newswire
    News headline image
    Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
    Via ACCESS Newswire
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress ↗
    Via Benzinga
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    News headline image
    S&P 500 Moves Lower; Walmart Shares Fall After Q2 Results ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Dow Dips Over 100 Points; US Initial Jobless Claims Increase ↗
    Via Benzinga
    Topics Stocks
    News headline image
    These stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    News headline image
    Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill

    Frequently Asked Questions

    Is Protagenic Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Protagenic Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Protagenic Therapeutics, Inc. - Common Stock trade on?
    Protagenic Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Protagenic Therapeutics, Inc. - Common Stock?
    The ticker symbol for Protagenic Therapeutics, Inc. - Common Stock is PTIX on the Nasdaq Stock Market
    What is the current price of Protagenic Therapeutics, Inc. - Common Stock?
    The current price of Protagenic Therapeutics, Inc. - Common Stock is 0.7400
    When was Protagenic Therapeutics, Inc. - Common Stock last traded?
    The last trade of Protagenic Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
    What is the market capitalization of Protagenic Therapeutics, Inc. - Common Stock?
    The market capitalization of Protagenic Therapeutics, Inc. - Common Stock is 1.34M
    How many shares of Protagenic Therapeutics, Inc. - Common Stock are outstanding?
    Protagenic Therapeutics, Inc. - Common Stock has 1M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.